---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-041749"
form_type: "8-K"
ticker: "VIVS"
cik: "0001497253"
company_name: "VivoSim Labs, INC."
filed_at: "2025-03-19T23:59:59+00:00"
generated_at: "2026-05-24T11:40:13.665388+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Organovo announces 1-for-12 reverse stock split effective March 20, 2025 to regain Nasdaq compliance

## Summary
- 1-for-12 reverse stock split effective 5:00 p.m. ET on March 20, 2025; adjusted trading begins March 21.
- Outstanding shares reduce from ~21.4M to ~1.8M; fractional shares paid in cash at March 19 closing price.
- Approved by shareholders on Nov 20, 2024; board selected 1-for-12 ratio on March 6, 2025.
- Intended to regain compliance with Nasdaq $1.00 minimum bid price for continued listing on Capital Market.

## SEC filing metadata
- accession: 0000950170-25-041749
- form_type: 8-K
- ticker: VIVS
- cik: 0001497253
- company_name: VivoSim Labs, INC.
- filed_at: 2025-03-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1497253/000095017025041749/0000950170-25-041749-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1497253/000095017025041749/onvo-20250319.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-041749
- JSON: https://secwatch.observer/filing/0000950170-25-041749.json
- Plain text: https://secwatch.observer/filing/0000950170-25-041749.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.